Chidamide Market SWOT Analysis by 2031
Chidamide is also known as CS055, and HBI-8000 is a subtype-selective benzamide HDAC (histone deacetylase) inhibitor. It increases histone H3 acetylation levels in colon cancer cells. It is a potential therapeutic drug used in the treatment of relapsed and refractory peripheral T-cell lymphoma (PTCL) cancer and various cancers such as hepatocellular carcinoma, hematological cancer, and bladder tumor. Chidamide not only inhibits tumor cells proliferation directly but also enhances the cellular immunity ability in various kinds of tumors.
MARKET SCOPE
The "Global Chidamide Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the chidamide market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading chidamide market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type, the global chidamide market is segmented into 5 mg and others.
- On the basis of application, the market is bifurcated into PECL treatment and other cancers treatment.
MARKET DYNAMICS
Drivers
- The increasing prevalence of cancer, growing aging population, and unhealthy lifestyle such as smoking drive the demand for the chidamide market.
- Increasing investment in research and development activities by major pharmaceutical companies fuels the market growth.
- Improving healthcare facilities in developing economies propel market growth.
Restraints
- High cost of drug.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The chidamide market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the chidamide market in these regions.
IMPACT OF COVID-19 ON CHIDAMIDE MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. Due to increasing cases of Covid-19, the government of many countries imposed lockdown, shutdown business resulting in trade disruptions, supply chain disruptions. Elective surgeries were also canceled to prevent virus transmission, and only emergency procedures were allowed to be carried out. This affected the chidamide market growth, as the drug demand was impacted. Although, after the removal of the restrictive measures, the market may witness slow growth in the future.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The chidamide market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the chidamide market in these regions.
IMPACT OF COVID-19 ON CHIDAMIDE MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. Due to increasing cases of Covid-19, the government of many countries imposed lockdown, shutdown business resulting in trade disruptions, supply chain disruptions. Elective surgeries were also canceled to prevent virus transmission, and only emergency procedures were allowed to be carried out. This affected the chidamide market growth, as the drug demand was impacted. Although, after the removal of the restrictive measures, the market may witness slow growth in the future.
MARKET PLAYERS
The report covers key developments in the chidamide market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from chidamide market are anticipated to have lucrative growth opportunities in the future with the rising demand for chidamide in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the chidamide market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Shenzhen Chipscreen
- HuyaBio
- GNT Biotech Medicals Corporation
- Japan Eisai
- Spectrum Pharmaceuticals
- Celegne
- Hutchison MediPharma
- Axon Medchem
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Chidamide Market - By Type
1.3.2 Chidamide Market - By Application
1.3.3 Chidamide Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CHIDAMIDE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CHIDAMIDE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CHIDAMIDE MARKET - GLOBAL MARKET ANALYSIS
6.1. CHIDAMIDE - GLOBAL MARKET OVERVIEW
6.2. CHIDAMIDE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. CHIDAMIDE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. 5 MG
7.3.1. Overview
7.3.2. 5 mg Market Forecast and Analysis
7.4. OTHERS
7.4.1. Overview
7.4.2. Others Market Forecast and Analysis
8. CHIDAMIDE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PECL TREATMENT
8.3.1. Overview
8.3.2. PECL Treatment Market Forecast and Analysis
8.4. OTHER CANCERS TREATMENT
8.4.1. Overview
8.4.2. Other Cancers Treatment Market Forecast and Analysis
9. CHIDAMIDE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Chidamide Market Overview
9.1.2 North America Chidamide Market Forecasts and Analysis
9.1.3 North America Chidamide Market Forecasts and Analysis - By Type
9.1.4 North America Chidamide Market Forecasts and Analysis - By Application
9.1.5 North America Chidamide Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Chidamide Market
9.1.5.1.1 Canada Chidamide Market by Type
9.1.5.1.2 Canada Chidamide Market by Application
9.1.5.2 Mexico Chidamide Market
9.1.5.2.1 Mexico Chidamide Market by Type
9.1.5.2.2 Mexico Chidamide Market by Application
9.1.5.3 US Chidamide Market
9.1.5.3.1 US Chidamide Market by Type
9.1.5.3.2 US Chidamide Market by Application
9.2. EUROPE
9.2.1 Europe Chidamide Market Overview
9.2.2 Europe Chidamide Market Forecasts and Analysis
9.2.3 Europe Chidamide Market Forecasts and Analysis - By Type
9.2.4 Europe Chidamide Market Forecasts and Analysis - By Application
9.2.5 Europe Chidamide Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Chidamide Market
9.2.5.1.1 Germany Chidamide Market by Type
9.2.5.1.2 Germany Chidamide Market by Application
9.2.5.2 France Chidamide Market
9.2.5.2.1 France Chidamide Market by Type
9.2.5.2.2 France Chidamide Market by Application
9.2.5.3 Italy Chidamide Market
9.2.5.3.1 Italy Chidamide Market by Type
9.2.5.3.2 Italy Chidamide Market by Application
9.2.5.4 Spain Chidamide Market
9.2.5.4.1 Spain Chidamide Market by Type
9.2.5.4.2 Spain Chidamide Market by Application
9.2.5.5 United Kingdom Chidamide Market
9.2.5.5.1 United Kingdom Chidamide Market by Type
9.2.5.5.2 United Kingdom Chidamide Market by Application
9.2.5.6 Rest of Europe Chidamide Market
9.2.5.6.1 Rest of Europe Chidamide Market by Type
9.2.5.6.2 Rest of Europe Chidamide Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Chidamide Market Overview
9.3.2 Asia-Pacific Chidamide Market Forecasts and Analysis
9.3.3 Asia-Pacific Chidamide Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Chidamide Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Chidamide Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Chidamide Market
9.3.5.1.1 Australia Chidamide Market by Type
9.3.5.1.2 Australia Chidamide Market by Application
9.3.5.2 China Chidamide Market
9.3.5.2.1 China Chidamide Market by Type
9.3.5.2.2 China Chidamide Market by Application
9.3.5.3 India Chidamide Market
9.3.5.3.1 India Chidamide Market by Type
9.3.5.3.2 India Chidamide Market by Application
9.3.5.4 Japan Chidamide Market
9.3.5.4.1 Japan Chidamide Market by Type
9.3.5.4.2 Japan Chidamide Market by Application
9.3.5.5 South Korea Chidamide Market
9.3.5.5.1 South Korea Chidamide Market by Type
9.3.5.5.2 South Korea Chidamide Market by Application
9.3.5.6 Rest of Asia-Pacific Chidamide Market
9.3.5.6.1 Rest of Asia-Pacific Chidamide Market by Type
9.3.5.6.2 Rest of Asia-Pacific Chidamide Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Chidamide Market Overview
9.4.2 Middle East and Africa Chidamide Market Forecasts and Analysis
9.4.3 Middle East and Africa Chidamide Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Chidamide Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Chidamide Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Chidamide Market
9.4.5.1.1 South Africa Chidamide Market by Type
9.4.5.1.2 South Africa Chidamide Market by Application
9.4.5.2 Saudi Arabia Chidamide Market
9.4.5.2.1 Saudi Arabia Chidamide Market by Type
9.4.5.2.2 Saudi Arabia Chidamide Market by Application
9.4.5.3 U.A.E Chidamide Market
9.4.5.3.1 U.A.E Chidamide Market by Type
9.4.5.3.2 U.A.E Chidamide Market by Application
9.4.5.4 Rest of Middle East and Africa Chidamide Market
9.4.5.4.1 Rest of Middle East and Africa Chidamide Market by Type
9.4.5.4.2 Rest of Middle East and Africa Chidamide Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Chidamide Market Overview
9.5.2 South and Central America Chidamide Market Forecasts and Analysis
9.5.3 South and Central America Chidamide Market Forecasts and Analysis - By Type
9.5.4 South and Central America Chidamide Market Forecasts and Analysis - By Application
9.5.5 South and Central America Chidamide Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Chidamide Market
9.5.5.1.1 Brazil Chidamide Market by Type
9.5.5.1.2 Brazil Chidamide Market by Application
9.5.5.2 Argentina Chidamide Market
9.5.5.2.1 Argentina Chidamide Market by Type
9.5.5.2.2 Argentina Chidamide Market by Application
9.5.5.3 Rest of South and Central America Chidamide Market
9.5.5.3.1 Rest of South and Central America Chidamide Market by Type
9.5.5.3.2 Rest of South and Central America Chidamide Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. CHIDAMIDE MARKET, KEY COMPANY PROFILES
11.1. SHENZHEN CHIPSCREEN
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. HUYABIO
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GNT BIOTECH MEDICALS CORPORATION
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. JAPAN EISAI
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. SPECTRUM PHARMACEUTICALS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. CELEGNE
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. HUTCHISON MEDIPHARMA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. AXON MEDCHEM
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1.Shenzhen Chipscreen
2.HuyaBio
3.GNT Biotech Medicals Corporation
4.Japan Eisai
5.Spectrum Pharmaceuticals
6.Celegne
7.Hutchison MediPharma
8.Axon Medchem
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For